CELYAD ONCOLOGY SA Retained Earnings
CELYAD ONCOLOGY SA had Retained Earnings of -EUR 353.69 million as of 2023-06-30, per its 6-K filed 2023-09-05.
Discontinued › Notes
ifrs-full:RetainedEarnings · last filed 2023-09-05
- 2023-06-30: Retained Earnings -353.69M EUR.
- 2022-12-31: Retained Earnings -349.95M EUR.
- 2022-06-30: Retained Earnings -323.05M EUR.
- 2021-12-31: Retained Earnings -309.00M EUR.
| Period end | Retained Earnings | Retained Earnings as first filed |
|---|---|---|
| 2023-06-30 | -353.69M EUR 6-K · filed 2023-09-05 | |
| 2022-12-31 | -349.95M EUR 6-K · filed 2023-09-05 | |
| 2022-06-30 | -323.05M EUR 6-K · filed 2022-08-05 | |
| 2021-12-31 | -309.00M EUR 20-F · filed 2023-03-23 | |
| 2021-06-30 | -63.33M EUR 6-K · filed 2021-08-04 | |
| 2020-12-31 | -283.04M EUR 20-F · filed 2022-03-24 | -91.83M EUR 20-F · filed 2021-03-24 |
| 2020-06-30 | -91.02M EUR 6-K · filed 2020-08-07 | |
| 2019-12-31 | -74.42M EUR 20-F · filed 2021-03-24 | |
| 2019-06-30 | -61.46M EUR 6-K/A · filed 2019-09-05 | |
| 2018-12-31 | -217.78M EUR 20-F · filed 2020-03-25 | |
| 2017-12-31 | -180.42M EUR 20-F · filed 2019-04-05 | |
| 2016-12-31 | -124.03M EUR 20-F · filed 2018-04-06 |